IP vs PACB
International Paper (IP) versus Pacific Biosciences of California (PACB) — a side-by-side from cached financials, not a winner call.
International Paper (IP) is a packaging & containers company listed on US.
Pacific Biosciences of California (PACB) is a medical devices company listed on US.
IP does not have a complete income-statement cache yet.
Latest reported PACB revenue for 2025-09-30 was $38.4M. Net income was -$38.0M. Revenue was down 3.3% from 2025-06-30 to 2025-09-30. PACB currently screens at market cap $387.1M.
IP currently screens at market cap $26.62B and trailing P/E 43.1. PACB currently screens at market cap $387.1M.
Not investment advice. Open the IP and PACB stock pages for the full models.
Not investment advice.